-transparent.png){kind=logo}
The effect of catechol-O-methyltransferase inhibition with nitecapone (OR-462) on the hemodynamic responses to exercise and catecholamine metabolism was studied in 10 healthy male volunteers (aged 19 to 26 years). Nitecapone, a new specific and selective catechol-O-methyltransferase inhibitor, was given at increasing single oral doses up to 100 mg. Nitecapone did not influence resting or exercise heart rate, blood pressure, systolic time intervals, or plasma catecholamine levels. It altered the metabolic profile of catecholamines as shown by (1) an increase of 140% in the plasma concentration of the monoamine oxidase-dependent metabolite 3,4-dihydroxyphenylethyleneglycol (p less than 0.001), (2) a decrease of 27% in the plasma concentration of its methylation product 3-methoxy-4-hydroxyphenylethyleneglycol (p less than 0.05), and (3) a 25% reduction in the urinary excretion of the methylated metabolites 3-methoxy-4-hydroxymandelic acid and homovanillic acid (p less than 0.05). Nitecapone was well tolerated and seemed to be hemodynamically safe in humans.
S Sundberg, and
M Scheinin, and
P Ojala-Karlsson, and
S Kaakkola, and
J Akkila, and
A Gordin
May 2022,
Drug testing and analysis,
S Sundberg, and
M Scheinin, and
P Ojala-Karlsson, and
S Kaakkola, and
J Akkila, and
A Gordin
January 2020,
Chemical & pharmaceutical bulletin,
S Sundberg, and
M Scheinin, and
P Ojala-Karlsson, and
S Kaakkola, and
J Akkila, and
A Gordin
January 1991,
European journal of clinical pharmacology,
S Sundberg, and
M Scheinin, and
P Ojala-Karlsson, and
S Kaakkola, and
J Akkila, and
A Gordin
January 1990,
Advances in neurology,
S Sundberg, and
M Scheinin, and
P Ojala-Karlsson, and
S Kaakkola, and
J Akkila, and
A Gordin
January 2002,
The European journal of neuroscience,
S Sundberg, and
M Scheinin, and
P Ojala-Karlsson, and
S Kaakkola, and
J Akkila, and
A Gordin
October 1997,
Journal of neurochemistry,
S Sundberg, and
M Scheinin, and
P Ojala-Karlsson, and
S Kaakkola, and
J Akkila, and
A Gordin
October 1990,
Clinical neuropharmacology,
S Sundberg, and
M Scheinin, and
P Ojala-Karlsson, and
S Kaakkola, and
J Akkila, and
A Gordin
January 1991,
Drug metabolism and disposition: the biological fate of chemicals,
S Sundberg, and
M Scheinin, and
P Ojala-Karlsson, and
S Kaakkola, and
J Akkila, and
A Gordin
September 1981,
Science (New York, N.Y.),
S Sundberg, and
M Scheinin, and
P Ojala-Karlsson, and
S Kaakkola, and
J Akkila, and
A Gordin
January 1993,
Drug metabolism and disposition: the biological fate of chemicals,
